|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0322 EUR | +6.62% |
|
+8.78% | +2.55% |
| 25-10-15 | GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report | CI |
| 25-10-15 | Geneuro SA postpones publication of half-yearly financial report | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.11M | - | - | - | - | - |
| 48.93B | |||||
| 43.15B | - | - | - | - | - |
| 40.48B | |||||
| 37.42B | |||||
| 31.03B |
- Stock Market
- Equities
- GNRO Stock
- Charts GeNeuro SA
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
